Cure My Disease

Don't miss your cure!

 Log in / Sign up

New stroke treatment Y-3 aims to boost recovery in first 48 hours

NCT ID NCT06517173

Completed Disease control Sponsor: Beijing Tiantan Hospital Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial tests whether an experimental drug called Y-3, given as an injection for 10 days, helps people recover better after an acute ischemic stroke. The study includes Chinese adults who had a stroke within the past 48 hours and have moderate to severe symptoms. Participants are randomly assigned to receive Y-3 or a placebo, and researchers measure recovery using a standard disability scale at 90 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Y-3 injection
What this could lead to
If effective, Y-3 could become a new treatment option to improve functional recovery after acute ischemic stroke.
What could go wrong
This is a Phase 3 trial, but Y-3 is still experimental. It may not prove more effective than placebo, and there could be unknown side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE ISCHEMIC STROKE

Contacts and locations

Locations

  • Beijing Tiantan Hospital Capital Medical University Beijing

    Beijing, Beijing Municipality, 100000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.